One of the most comprehensive reports on gender identity was published on Wednesday by NHS England and it concludes that studies on transgender hormones for young people have been “poor quality” and that for “most young people, a medical pathway will not be the best way to manage their gender-related distress.”
This comes from the Cass Review, a 388-page “independent review of gender identity services for children and young people.” The conclusions will come as no surprise to anyone who has read actual research on transgender medicalization or social research. It shows that there IS an element of social contagion to gender dysphoria that has disproportionately affected young girls. It shows that these girls are NOT being treated for pre-existing conditions such as autism and other mental health issues but they should be. It shows that there IS a serious risk of harm from hormonal treatment and surgery that is often ignored and it shows that most studies of people who have undergone this treatment have a high drop-off rate and short period of follow up.
This is consistent with the findings of the WPATH Files.
Trans activists pushed back against the Cass Report with the line that this research will “suffer and die” if they don’t get medicalization. This is a lie. Research shows that people who DO transition have a higher suicide attempt and success rate than people who do not.
